Data / Form D filings / VST BIO Corp
VST BIO Corp: Form D filings
VST BIO Corp, a pharmaceuticals company in San Diego, CA, filed 2 Form D notices with the SEC between 2025 and 2026. The latest, on April 24, 2026, reports $31.9 million sold of a $31.9 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4653 CARMEL MOUNTAIN ROAD, STE 308 PMB 1015, San Diego, CA, 92130
- Phone
- (858) 663-8641
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2093250
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | Amendment | $31,888,146 | $31,888,146 | 1 | Nov 5, 2025 | sec.gov | |
| Nov 18, 2025 | New notice | $28,888,146 | $28,888,146 | 1 | Nov 5, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Krisztina Zsebo | Executive Officer, Director | |
| Rebecque Laba | Executive Officer | |
| David Cheresh | Director | |
| J. Anthony Ware | Director | |
| Chris Somerville | Director | |
| William Sessa | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Apr 20, 2026 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what VST BIO Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.